X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7311) 7311
Dissertation (45) 45
Book Chapter (41) 41
Conference Proceeding (38) 38
Publication (22) 22
Magazine Article (15) 15
Newspaper Article (10) 10
Trade Publication Article (5) 5
Book / eBook (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5204) 5204
life sciences & biomedicine (4737) 4737
immunotherapy (3113) 3113
pd-1 (3091) 3091
pd-1 protein (3084) 3084
humans (2732) 2732
oncology (2570) 2570
lymphocytes t (1846) 1846
cancer (1776) 1776
lymphocytes (1713) 1713
immunology (1682) 1682
tumors (1655) 1655
apoptosis (1545) 1545
pd-l1 protein (1540) 1540
immune checkpoint (1495) 1495
pd-l1 (1442) 1442
female (1298) 1298
melanoma (1257) 1257
patients (1211) 1211
male (1111) 1111
animals (1080) 1080
t cells (987) 987
cell death (923) 923
metastasis (887) 887
middle aged (851) 851
cd8 antigen (796) 796
antigens (795) 795
lung cancer (794) 794
metastases (791) 791
chemotherapy (783) 783
cancer therapies (777) 777
immune system (742) 742
cytotoxicity (732) 732
care and treatment (731) 731
ligands (731) 731
aged (713) 713
programmed cell death 1 receptor - antagonists & inhibitors (708) 708
clinical trials (696) 696
mice (685) 685
adult (660) 660
pembrolizumab (654) 654
nivolumab (613) 613
ctla-4 (612) 612
immune response (610) 610
programmed cell death 1 receptor - immunology (596) 596
ctla-4 protein (581) 581
research (564) 564
programmed cell death 1 receptor - metabolism (560) 560
biomarkers (554) 554
antibodies (552) 552
gene expression (549) 549
cd4 antigen (541) 541
flow cytometry (521) 521
proteins (519) 519
cytokines (517) 517
analysis (513) 513
medical prognosis (497) 497
health aspects (488) 488
cell biology (485) 485
immunohistochemistry (474) 474
review (466) 466
prognosis (464) 464
science & technology - other topics (460) 460
medicine (455) 455
immunotherapy - methods (446) 446
multidisciplinary sciences (446) 446
medical research (439) 439
neoplasms. tumors. oncology. including cancer and carcinogens (438) 438
monoclonal antibodies (432) 432
mutation (430) 430
medicine, research & experimental (425) 425
research & experimental medicine (425) 425
b7-h1 antigen - metabolism (420) 420
t cell receptors (418) 418
antibodies, monoclonal - therapeutic use (416) 416
medicine & public health (399) 399
immunoglobulins (381) 381
cell activation (379) 379
research article (379) 379
non-small cell lung carcinoma (370) 370
inflammation (366) 366
tumor cells (362) 362
treatment outcome (361) 361
b7-h1 antigen - antagonists & inhibitors (356) 356
cd8-positive t-lymphocytes - immunology (348) 348
science (347) 347
anti-pd-1 (318) 318
b7-h1 antigen - immunology (317) 317
t-lymphocytes - immunology (317) 317
aged, 80 and over (314) 314
studies (313) 313
immunity (311) 311
neoplasms - immunology (311) 311
drug therapy (304) 304
biochemistry & molecular biology (302) 302
cell line, tumor (299) 299
antineoplastic agents - therapeutic use (297) 297
signal transduction (296) 296
antitumor activity (294) 294
toxicity (293) 293
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7032) 7032
Chinese (319) 319
French (47) 47
Japanese (45) 45
German (43) 43
Korean (25) 25
Russian (24) 24
Polish (7) 7
Czech (6) 6
Portuguese (5) 5
Italian (4) 4
Spanish (3) 3
Dutch (2) 2
Hungarian (2) 2
Norwegian (2) 2
Slovenian (2) 2
Turkish (2) 2
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncoimmunology, ISSN 2162-402X, 12/2018, Volume 8, Issue 3, p. 1557030
Under physiological conditions, PD-1/PD-L1 interactions regulate unwanted over-reactions of immune cells and contribute to maintain peripheral tolerance.... 
PD-1 cytoplasmic pool | mRNA isoforms | bright | dim | Natural killer cells | PD-1 | CD56 | checkpoint inhibitors | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | cd56dim cd56bright | natural killer cells | pd-1 cytoplasmic pool | pd-1 | mrna isoforms
Journal Article
Journal Article
Journal for immunotherapy of cancer, ISSN 2051-1426, 01/2018, Volume 6, Issue 1, pp. 1 - 9
Background: An elevated Neutrophil-to-lymphocyte ratio (NLR) is associated with worse outcomes in several malignancies. However, its role with contemporary... 
PD-1/pd-L1 PD-L1 | Neutrophil-to-lymphocyte ratio | Renal cell carcinoma | Immunotherapy | Prognostic biomarker | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | PD-1/pd-L1 PD-L1
Journal Article
Oncotarget, ISSN 1949-2553, 02/2019, Volume 10, Issue 12, pp. 1228 - 1229
Journal Article
Cancer, ISSN 0008-543X, 09/2017, Volume 123, Issue 17, pp. 3285 - 3290
BACKGROUND Immunotherapy has changed the therapeutic landscape in oncology. Advanced uterine leiomyosarcoma (ULMS) remains an incurable disease in most cases,... 
uterine leiomyosarcoma | sarcoma | nivolumab | immunotherapy | anti–programmed‐death 1 (PD‐1) | anti–programmed-death 1 (PD-1) | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Age Factors | Uterine Neoplasms - pathology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Dose-Response Relationship, Drug | Neoplasm Invasiveness - pathology | Uterine Neoplasms - mortality | Adult | Female | Retrospective Studies | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Leiomyosarcoma - pathology | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Survival Analysis | Uterine Neoplasms - drug therapy | Leiomyosarcoma - mortality | Leiomyosarcoma - drug therapy | Aged | Infusions, Intravenous | Neoplasm Staging | Cohort Studies | Usage | Uterus | Immunotherapy | Leiomyosarcoma | Research | Gene expression | Drug therapy | Health aspects | Health care | Intravenous administration | Statistical analysis | Sarcoma | PD-1 protein | Toxicity | Immunomodulation | Tumor cells | Phenotypic variations | Statistical methods | Patients | Survival | Modulators | Confidence intervals | Population (statistical) | Immune checkpoint | PD-L1 protein | Phenotyping | Biomarkers | Toxic diseases | Cancer | Immune system | Index Medicus | Abridged Index Medicus | programmed-death 1 (PD-1) | anti
Journal Article
Angewandte Chemie (International ed.), ISSN 1433-7851, 10/2017, Volume 56, Issue 44, pp. 13732 - 13735
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 05/2019, Volume 116, Issue 20, pp. 9999 - 10008
Journal Article